Guardant Health, Inc.GG

Guardant Health, Inc.

36.71USDR
+0.11+0.31%
At close at 00:18 UTC
USD
No trades
See on Supercharts

Price target

42.70RUSD+6.00+16.33%
The 20 analysts offering 1 year price forecasts for Guardant Health, Inc. have a max estimate of 60.00 and a min estimate of 19.00.

Analyst rating

Based on 24 analysts giving stock ratings to Guardant Health, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
18
Buy
4
Hold
1
Sell
0
Strong sell
1

EPS

Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪−1.60‬
‪−1.20‬
‪−0.80‬
‪−0.40‬
‪0.00‬
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
‪−1.30‬
‪−0.67‬
‪−0.73‬
‪−1.58‬
‪−0.94‬
‪−0.84‬
‪−0.88‬
Estimate
‪−1.34‬
‪−1.22‬
‪−0.97‬
‪−0.86‬
‪−0.88‬
‪−0.75‬
‪−0.73‬
‪−0.78‬
‪−0.77‬
‪−0.74‬
‪−0.77‬
Surprise
+2.82%
+44.96%
+24.55%
−83.27%
−6.91%
−11.48%
−20.48%

Revenue

Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
‪‪128.71 M‬‬
‪‪137.15 M‬‬
‪‪143.03 M‬‬
‪‪155.05 M‬‬
‪‪168.49 M‬‬
‪‪177.24 M‬‬
‪‪191.48 M‬‬
Estimate
‪‪117.87 M‬‬
‪‪129.85 M‬‬
‪‪137.35 M‬‬
‪‪149.60 M‬‬
‪‪150.09 M‬‬
‪‪162.59 M‬‬
‪‪170.49 M‬‬
‪‪186.74 M‬‬
‪‪190.64 M‬‬
‪‪204.66 M‬‬
‪‪218.77 M‬‬
Surprise
+9.20%
+5.62%
+4.14%
+3.65%
+12.26%
+9.01%
+12.31%
Be warned

Frequently Asked Questions


GH EPS for the last quarter is −0.88 USD despite the estimation of −0.73 USD. In the next quarter EPS is expected to reach −0.78 USD. Track more of Guardant Health, Inc. financials and stay on top of what is up with the company.
In the next quarter Guardant Health, Inc. revenue is expected to reach ‪186.74 M‬ USD. Check out Guardant Health, Inc. revenue and earnings and make informed decisions.
According to analysts, GH price target is 42.70 USD with a max estimate of 60.00 USD and a min estimate of 19.00 USD. Check if this forecast comes true in a year, meanwhile watch Guardant Health, Inc. stock price chart and keep track of the current situation with GH news and stock market news.
We've gathered opinions of 24 analysts rating GH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.